Learn about our patients and the patient care provided by the Comprehensive Breast Program.
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Participating in clinical trials gives breast cancer patient Amy Visser-Lynch a new outlook on life.
In February 2013, Debra Beaupre was waiting to hear back from Harvard about graduate school. She never expected that she would begin an entirely different journey - treatment for breast cancer.
NCCC surgeons work together to offer new tissue-sparing and nipple-sparing surgery methods, same-day breast reconstruction, and follow-up care to help women find treatment that reflects their values.
NCCC recently installed a real-time monitoring system that allows technicians to monitor the patient as she holds a deep breath for 20 seconds so radiation is precisely targeted.